Department of Surgery, National Hospital Organization, Hakodate Hospital, 18-16 Kawahara-cho, Hakodate, 041-8512, Japan.
World J Surg. 2011 Feb;35(2):349-56. doi: 10.1007/s00268-010-0880-y.
Tumor budding is defined as an isolated single cancer cell or a cluster of cancer cells composed of fewer than five cells at the invasive front of a tumor. The aim of the present study was to identify correlations between tumor budding and clinicopathological factors and their impact on postoperative prognosis in invasive squamous cell carcinoma of the thoracic esophagus.
The subjects were 82 patients who underwent curative resection. The number of tumors showing budding was counted immunohistochemically based on positivity for cytokeratin (AE1/AE3) to distinguish cancer cells from inflammatory cells, and the patients were divided into low-grade and high-grade budding groups. High-grade budding was defined as ≥5 budding foci per field under a 20× objective lens.
One group of 36 patients (43.9%) and a second group of 46 patients (56.1%) were classified into the low-grade and high-grade budding groups, respectively. Patients in the high-grade budding group had significantly larger tumor size, deeper depth of invasion, more frequent lymphatic invasion and venous invasion, as well as more lymph node metastases, than those in the low-grade budding group. Disease-free and overall survivals were worse in the high-grade budding group than in the low-grade budding group (P<0.0001 and P=0.0002, respectively). Three of four patients who had tumor recurrence more than 5 years postoperatively belonged to the low-grade budding group.
Tumor budding appears to be an indicator of tumor growth and invasiveness. Patients with low-grade budding are likely to have a better prognosis than those with high-grade budding, but the tumor may recur in the late phase postoperatively in patients with low-grade budding.
肿瘤芽是指肿瘤侵袭前沿的孤立单个癌细胞或由少于 5 个细胞组成的癌细胞簇。本研究的目的是确定肿瘤芽与临床病理因素之间的相关性及其对胸段食管浸润性鳞状细胞癌术后预后的影响。
本研究纳入了 82 例接受根治性切除术的患者。通过免疫组织化学方法根据细胞角蛋白(AE1/AE3)的阳性来计数肿瘤芽的数量,以区分癌细胞和炎症细胞,并将患者分为低级别和高级别芽组。高级别芽定义为在 20×物镜下每视野有≥5 个芽灶。
一组 36 例(43.9%)患者和另一组 46 例(56.1%)患者分别归入低级别和高级别芽组。高级别芽组患者的肿瘤大小、浸润深度、淋巴管和静脉侵犯以及淋巴结转移更为显著,与低级别芽组相比。高级别芽组的无病生存率和总生存率均低于低级别芽组(P<0.0001 和 P=0.0002)。术后 5 年以上肿瘤复发的 4 例患者中有 3 例属于低级别芽组。
肿瘤芽似乎是肿瘤生长和侵袭性的指标。低级别芽患者的预后可能优于高级别芽患者,但低级别芽患者术后可能在晚期复发。